References
- Akahoshi T, Murakami Y, Kitasato H. Recent advances in crystal-induced acute inflammation. Curr Opin Rheumatol. 2007;19:146–150.
- Kingsbury SR, Conaghan PG, McDermott MF. The role of the NLRP3 inflammasome in gout. J Inflamm Res. 2011;4:39–49.
- Martinon F. Mechanisms of uric acid crystal-mediated autoinflammation. Immunol Rev. 2010;233:218–232.
- El-Shanti H, Majeed HA, El-Khateeb M. Familial Mediterranean fever in Arabs. Lancet. 2006;367:1016–1024.
- Ben-Chetrit E, Peleg H, Aamar S, Heyman SN. The spectrum of MEFV clinical presentations—is it familial Mediterranean fever only? Rheumatology (Oxford). 2009;48:1455–1459.
- Shimizu M, Tone Y, Toga A, Yokoyama T, Wada T, Toma Tet al. Colchicine-responsive chronic recurrent multifocal osteomyelitis with MEFV mutations: a variant of familial Mediterranean fever? Rheumatology (Oxford). 2010;49:2221–2223.
- Miao ZM, Zhao SH, Wang YG, Li CG, Wang ZC, Chen Yet al. Epidemiological survey of hyperuricemia and gout in coastal areas of Shandong province. Chin J Endocrinol Metab. 2006;22:421–425.
- Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237–241.
- Miao ZM, Zhao SH, Yan SL, Li CG, Wang YG, Meng DMet al. NALP3 inflammasome functional polymorphisms and gout susceptibility. Cell Cycle. 2009;8:27–30.
- Keith MP, Gilliland WR. Updates in the management of gout. Am J Med. 2007;120:221–224.
- Jordan KM, Cameron JS, Snaith M, Zhang W, Doherty M, Seckl Jet al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford). 2007;46:1372–1374.
- Chae JJ, Aksentijevich I, Kastner DL. Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol. 2009;146:467–478.
- Grandemange S, Aksentijevich I, Jeru I, Gul A, Touitou I. The regulation of MEFV expression and its role in health and familial Mediterranean fever. Genes Immun. 2011;12:497–503.
- Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet. 2001;9:473–483.
- Migita K, Ida H, Moriuchi H, Agematsu K. Clinical relevance of MEFV gene mutations in Japanese patients with unexplained fever. J Rheumatol. 2012;39:875–877.
- Cronstein BN, Terkeltaub R. The inflammatory process of gout and its treatment. Arthritis Res Ther. 2006;8:S3
- Tchernitchko DO, Gérard-Blanluet M, Legendre M, Cazeneuve C, Grateau G, Amselem S. Intrafamilial segregation analysis of the p.E148Q MEFV allele in familial Mediterranean fever. Ann Rheum Dis. 2006;65:1154–1157.
- Cañete JD, Arostegui JI, Queiró R, Gratacós J, Hernández MV, Larrosa Met al. An unexpectedly high frequency of MEFV mutations in patients with anti-citrullinated protein antibody-negative palindromic rheumatism. Arthritis Rheum. 2007;56:2784–2788.
- Karban A, Dagan E, Eliakim R, Herman A, Nesher S, Weiss Bet al. Prevalence and significance of mutations in the familial Mediterranean fever gene in patients with Crohn’s disease. Genes Immun. 2005;6:134–139.
- Akkoc N, Gul A. Familial Mediterranean fever and seronegative arthritis. Curr Rheumatol Rep. 2011;13:388–394.